According to relevant statistics, my country's pharmaceutical packaging industry has maintained an average annual growth rate of more than 10% in recent years, and its gross production value has accounted for more than 10% of the national packaging industry's gross output value, which is higher than the proportion of the pharmaceutical industry in the national gross industrial output value. .

It is understood that after medicines are packed in packaging materials, migration, permeation, corrosion, adsorption, etc. may also occur, which will affect the quality of the medicines. Therefore, the research on the compatibility of packaging materials is still the key.

The compatibility experiment is to investigate whether these phenomena occur between the drug packaging material and the drug, and its purpose is to ensure the safety, effectiveness and uniformity of the drug. The research in this aspect of domestic pharmaceutical companies is even more inadequate. Therefore, the compatibility of pharmaceutical packaging materials will be the focus of the work of the regulatory authorities in the future.

Relevant experts pointed out that my country's pharmaceutical packaging industry will focus on the development of new, environmentally friendly, degradable, and easy-to-use pharmaceutical packaging materials and containers in the next five years. According to the 2010-2013 China Pharmaceutical Packaging Market Analysis and Investment Strategy Research Report released by Shangpu Consulting, due to the rapid development of the pharmaceutical industry, the production capacity expansion of my country's pharmaceutical packaging industry has basically been completed. However, a new round of competition is about to begin. The compatibility of pharmaceutical packaging is the primary problem that my country's pharmaceutical packaging factories should break through.

The domestic pharmaceutical packaging field is still in the stage of being large but not strong. It is necessary to strengthen the research and development of new materials and new processes, especially the problem of material compatibility that needs to be solved urgently. The "Twelfth Five-Year Plan" of the pharmaceutical packaging industry will re-incorporate many previously unregulated content into the scope of supervision. This makes pharmaceutical companies must pay more attention to the compatibility of packaging materials. This is a rare opportunity for pharmaceutical packaging companies. .